2020 Updates in Inflammatory Bowel Disease
Updates in Inflammatory Bowel Disease will provide participants with current safety and efficacy data for novel therapies, considerations for special populations with IBD and health maintenance best practices. The course will consist of lectures and case-based presentations from expert IBD providers from Wisconsin.
There is a need for further understanding of mechanisms, efficacy data, and side effect profiles of currently approved treatments for IBD on the part of community based practicing gastroenterologists.
Special populations within the IBD community such as pregnant women, parents of pediatric patients and pediatric patients have poor understanding of key management issues for IBD.
Providers may not utilize available healthcare resources to ensure their patients adhere to vaccine and surveillance schedules.
ELEMENTS OF COMPETENCE
This CE activity has been designed to improve learner competence and focuses on the American Board of Medical Specialties’ areas of medical knowledge, and patient care and procedural skills.
This activity also focuses on the Interprofessional competencies of roles/responsibilities, Interprofessional communication, and teams/teamwork.
This activity is designed for physicians, nurses, advanced practice providers, and physician assistants who are looking to enhance their knowledge and skills for the care of their patients with IBD.
At the conclusion of this educational activity, the healthcare team will be able to:
1) List the current and future treatments for IBD and understand the mechanisms of action, efficacy data, and side effect profiles for each treatment.
2) Apply knowledge gained regarding current protocols for managing special populations with IBD.
3) Identify key health maintenance items relevant to all IBD patients.
Jointly Provided by
Crohn's and Colitis Foundation, Wisconsin Chapter
University of Wisconsin–Madison Interprofessional Continuing Education Partnership (ICEP)
|8:00||Welcome and Introductions|
|8:15||Very Early Onset IBD, a Lesson in the Genetics of all IBD|
Abdul Elkadri, MD
|8:45||Therapeutic Drug Monitoring|
Ian Grimes, MD
|9:15||Emerging Stem Cell Therapy for Fistulizing Perianal Crohn's Disease|
Poonam Beniwal-Patel, MD
|10:00||New Therapies in IBD|
Daniel Stein, MD
|10:30||Preventive Care in IBD|
Freddy Caldera, DO, MS
|11:00||Pregnancy and IBD|
Sumona Saha, MD, MS
Moderator: Freddy Caldera, DO, MS
*Freddy Caldera, DO, MS; Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health
*Poonam Beniwal-Patel, MD; Assistant Professor of Medicine, Division of Gastroenterology, Medical College of Wisconsin
*Monica Zablotney, NP; Department of Medicine, Division of Gastroenterology, University of Wisconsin Medical Foundation, Inc.
PRESENTERS, MODERATORS & PLANNERS
*Terese Bailey, BS; Accreditation Specialist, University of Wisconsin–Madison ICEP
Poonam Beniwal-Patel, MD; Assistant Professor of Medicine, Division of Gastroenterology, Medical College of Wisconsin
Freddy Caldera, DO, MS; Assistant Professor of Medicine, University of Wisconsin School of Medicine and Public Health
Abdul Elkadri, MD; Assistant Professor, Department of Gastroenterology and Hepatology, Children's Hospital of Wisconsin
*Mary Esna-Ashari, MPH; National Education Director, Crohn’s & Colitis Foundation
*Kelly Fitzgerald; Crohn's & Colitis Foundation
Ian Grimes, MD; Assistant Professor of Medicine, Division of Gastroenterology, University of Wisconsin School of Medicine and Public Health
Sumona Saha, MD; Associate Professor of Medicine, Divsion of Gastroenterology, Unviersity of Wisconsin School of Medicine and Public Health
Daniel Stein, MD; Associate Professor of Gastroenterology and Hepatology, Froedtert and the Medical College of Wisconsin
In support of improving patient care, this activity has been planned and implemented by the University of Wisconsin–Madison ICEP and the Crohn’s & Colitis Foundation, Wisconsin Chapter. The University of Wisconsin–Madison ICEP is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CREDIT DESIGNATION STATEMENTS
American Medical Association (AMA)
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC) & Iowa Board of Nursing
The University of Wisconsin–Madison ICEP designates this live activity for a maximum of 3.5 ANCC and Iowa Board of Nursing contact hours.
The University of Wisconsin-Madison School of Nursing is Iowa Board of Nursing provider 350. A copy of the evaluation(s) may be sent to the Iowa Board of Nursing, 400 SW 8th St., Suite B, Des Moines, IA 50309.
Continuing Education Units (CEUs)
The University of Wisconsin–Madison, as a member of the University Professional Continuing Education Association (UPCEA), authorizes this program for 3.5 continuing education units (CEUs) or 0.35 hours.
- 3.50 AMA PRA Category 1 Credit™
- 3.50 ANCC Contact Hours
- 3.50 Iowa Board of Nursing Contact Hours
- 3.50 University of Wisconsin–Madison Continuing Education Hours
Syllabus & Conference Materials
Conference materials will be available to registered participants 48 hours prior to the event at this conference site.
Emergency situations occasionally occur and may necessitate topic or speaker changes. The University of Wisconsin–Madison ICEP and the Crohn's & Colitis Foundation, Wisconsin Chapter reserve the right to alter or substitute a topic or speaker without prior notification.
FOR FURTHER INFORMATION
For conference information, please contact Mary Esna-Ashari, MPH at 404-982-0616 or email@example.com.